Back to top

Larimar Therapeutics assumed with a Buy at H.C. Wainwright

H.C. Wainwright assumed coverage of Larimar Therapeutics (LRMR) with a Buy rating and $10 price target The company’s biologics license application ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Larimar Therapeutics, Inc. (LRMR)